Purinoceptors on Neuroglia

Purinergic transmission is one of the most ancient and widespread extracellular signalling systems. In the brain, purinergic signalling plays a unique role in integrating neuronal and glial cellular circuits, as virtually every type of glial cell possesses receptors to purines and pyrimidines. These receptors, represented by metabotropic P1 adenosine receptors, metabotropic P2Y purinoceptors and ionotropic P2X purinoceptors, control numerous physiological functions of glial cells and are intimately involved in virtually every form of neuropathology. In this essay, we provide an in depth overview of purinoceptor distribution in two types of CNS glia—in astrocytes and oligodendrocytes—and discuss their physiological and pathophysiological roles. An erratum to this article can be found at     

Single Cell Measurements in Research on Calcium-Mobilising Purinoceptors

Abstract

The Ca-sensitive photoprotein aequorin has been used to record repetitive free Ca transients in single rat liver cells responding to either ATP or ADP. The time-course of individual transients is longer when ATP is the agonist. If both agonists operate through the same receptor, then curtailment of the receptors' activity occurs more rapidly when ADP is the agonist, and we infer that an agonist-occupied receptor linked to a GTP-liganded G protein is the moiety responsible for activating a phosphatidylinositol bisphosphate-specific phospholipase C. The alternative explanation is that ATP and ADP act through different receptors.     

Purinoceptors in blood feeding behaviour in the stable fly, Stomoxys calcitrans

Abstract Both sexes of the stable fly, Stomoxys calcitrans L. (Diptera: Muscidae), have receptors on their mouthparts that mediate blood feeding. The potency ranking of the adenine nucleotides (ATP > ADP > AMP > adenosine) in eliciting feeding and suppressing the NaCl-sensitive cell may indicate the involvement of a P₂-type receptor. This is supported by the lack of effect on feeding by methyl xanthines. Feeding-related behavioural and electrophysiological results demonstrate that the potency of CH₃-S-ATP is not greater than that of ATP. These ATP-mediated responses are antagonized by ANAPP₃. Results support the conclusion that the putative 'ATP receptor' involved in stable fly phagostimulation resembles the P_2x purinoceptor of vertebrates.     

川芎嗪对蟾蜍交感神经节细胞膜嘌呤受体介导反应的调制作用

采用细胞外微电极技术,记录离体灌流的蟾蜍椎旁交感神经节细胞膜电位,观察川芎嗪对嘌呤受体介导反应的调制作用。三磷酸腺苷（３００μｍｏｌ／Ｌ）可引起神经节细胞膜去极化（ｎ＝６２）、超极化反应（ｎ＝２７）以及去极化之后伴随超极化过程的双相反应（ｎ＝９）。Ｐ２受体拮抗剂台盼蓝（５００μｍｏｌ／Ｌ）可抑制三磷酸腺苷的去极化反应（ｎ＝８）;Ｐ１受体拮抗剂氨茶碱（２００μｍｏｌ／Ｌ）可抑制三磷酸腺苷的超极化反应（ｎ＝７）。滴加川芎嗪（１～５ｍｍｏｌ／Ｌ）,神经节细胞膜未出现明显的电位变化。外源性环－磷酸腺苷（２５０μｍｏｌ／Ｌ）可模拟三磷酸腺苷的超极化反应（ｎ＝９）。川芎嗪（３ｍｍｏｌ／Ｌ）可抑制三磷酸腺苷的去极化反应,使其幅值减少５３９±９５％（ｎ＝１４,Ｐ＜００１）,并能加强三磷酸腺苷所致超极化反应,使其幅值增大１０５４±２４５％（ｎ＝１２,Ｐ＜００１）。在同一标本上,川芎嗪使环一磷酸腺苷的超极化反应加强（ｎ＝４）。此外,川芎嗪可抑制三磷酸腺苷引起的双相反应中的去极相,而增大其后的超极相（ｎ＝３）。     

Lipoxynoids in the kidney

There are a variety of non-prostaglandin pathways for conversion of arachidonic acid, including lipoxygenase enzymes and epoxygenase enzymes such as cytochrome P-450. In a manner similar to that in which the cyclooxygenase pathways lead to the prostanoid family, ‘lipoxynoids’ refers to the family of products arising from this alternative group of pathways.Leukotrienes (LT's) are members of the lipoxynoid family arising from the action of 5-lipoxygenase enzymes. In the canine kidney, injections of leukotrienes C₄, D₄ and E₄ into the renal artery produced weak vasodilation at doses of 3–30 ug. Responses to LTC₄ and LTD₄ were similar and greater than responses to LTE₄, and responses were not different in animals which had received ibuprofen to inhibit prostaglandin synthesis. In contrast, these leukotrienes were potent vasoconstrictors of the mesenteric vascular bed in these same animals at doses of 0.01–0.3 ug. The order of potency was LTD₄ LTC₄ LTE₄. Effects of these LT's were not changed in the presence of ibuprofen. Responses to LTC₄ and LTD₄, but not LTE₄ were diminished approximately 50% after administration of FPL-55712 (2 mg/kg). Neither LTB₄ nor 5-HETE produced any change in renal or mesenteric blood flow at doses up to 30 ug.However, indirect evidence has been obtained suggesting that an endogenous lipoxynoid pathway can be activated in the canine kidney which results in the formation of a vasoconstrictor product. Injections of 1–4 mg AA into the renal artery of water-replete dogs leads to vasodilation which can be blocked by inhibitors of cyclooxygenase enzymes. However, when dogs were water deprived for 16–20 hours before the experiment, biphasic changes in renal blood flow were found. Ibuprofen blocked the vasodilator phase of the response but neither ibuprofen or the thromboxane synthesis inhibitor OKY-1581 had any inhibitory effect on the constrictor phase. The constrictor phase was blocked only following administration of ETYA or BW-755C, suggesting that the metabolites responsible for the constriction were lipoxynoids. Since LT's produce renal vasodilation, it appears that the pathway involved is not the 5-lipoxygenase system. These data suggest that other lipoxynoid pathways (e.g. 12-lipoxygenase, 15-lipoxygenase or cytochrome p-450) may play a role in the renal response to water deprivation. At present, however, it may not be possible to distinguish between these possible pathways .     

Ectonucleotidases in the kidney

Members of all four families of ectonucleotidases, namely ectonucleoside triphosphate diphosphohydrolases (NTPDases), ectonucleotide pyrophosphatase/phosphodiesterases (NPPs), ecto-5′-nucleotidase and alkaline phosphatases, have been identified in the renal vasculature and/or tubular structures. In rats and mice, NTPDase1, which hydrolyses ATP through to AMP, is prominent throughout most of the renal vasculature and is also present in the thin ascending limb of Henle and medullary collecting duct. NTPDase2 and NTPDase3, which both prefer ATP over ADP as a substrate, are found in most nephron segments beyond the proximal tubule. NPPs catalyse not only the hydrolysis of ATP and ADP, but also of diadenosine polyphosphates. NPP1 has been identified in proximal and distal tubules of the mouse, while NPP3 is expressed in the rat glomerulus and pars recta, but not in more distal segments. Ecto-5′-nucleotidase, which catalyses the conversion of AMP to adenosine, is found in apical membranes of rat proximal convoluted tubule and intercalated cells of the distal nephron, as well as in the peritubular space. Finally, an alkaline phosphatase, which can theoretically catalyse the entire hydrolysis chain from nucleoside triphosphate to nucleoside, has been identified in apical membranes of rat proximal tubules; however, this enzyme exhibits relatively high K _m values for adenine nucleotides. Although information on renal ectonucleotidases is still incomplete, the enzymes’ varied distribution in the vasculature and along the nephron suggests that they can profoundly influence purinoceptor activity through the hydrolysis, and generation, of agonists of the various purinoceptor subtypes. This review provides an update on renal ectonucleotidases and speculates on the functional significance of these enzymes in terms of glomerular and tubular physiology and pathophysiology.     

Self-renewal in the fly kidney

Tissue stem cells are typically rare and located in niches that prescribe low rates of cell division and survival. In the latest issue of Cell Stem Cell, Singh et al. (2007) demonstrate that, in the adult fly, epithelial cells exist that are neither in niches nor in small numbers, divide at high rates, and are multipotent.     

Apicobasal polarity in the kidney

The apicobasal polarization of epithelia is critical for many aspects of kidney function. Over the last decade there have been major advances in our understanding of the mechanisms that underlie this polarity. Critical to this understanding has been the identification of protein complexes on the apical and basolateral sides of epithelial cells that act in a mutually antagonistic manner to define these domains. Concomitant with the creation of apical and basolateral domains is the formation of highly specialized cell-cell junctions including adherens junctions and tight junctions. Recent research points to variability in the polarity and junctional complexes amongst different species and between different cell types of the kidney. Defects in apicobasal polarity are prominent in several disorders including acute renal failure and polycystic kidney disease.     

Corticosteroid receptors in the avian kidney

The binding $\text{in vitro}$ of tritiated aldosterone to domestic duck ($\text{Anas platyrhynchos}$) kidney tissue has been investigated. Using tissue from animals on a normal diet, tritiated aldosterone was specifically bound to kidney cytosol with an apparent equilibrium dissociation constant of about 9 nM and number of binding sites in the 20 fmol/mg protein range. These values did not show statistically significant changes when the cytosol originated from animals with salt activated nasal glands. Kidney cytosols labeled with tritiated aldosterone sedimented with a single peak at 8S in a linear sucrose gradient (10–30%) and this peak was quenched by excess, radioinert aldosterone. Following incubation of labeled cytosols with crude nuclei, the cytosols became depleted of the label and aldosterone was translocated to the Tris-soluble and Tris-insoluble, 0,4 M KCl soluble nuclear fractions. Kidney cytosols metabolized aldosterone extensively to a compound presumed to be 3α,5β-tetrahydroaldosterone. However, only unchanged aldosterone became receptor-bound. It was concluded that the duck kidney possesses aldosterone receptors, though competition studies indicated that the specificity of these receptors might be different from those described in the mammalian kidney.     

Conditional gene targeting in the kidney

Complete mapping of the genome in a number of organisms provides a challenge for experimental nephrologists to identify potential functions of a vast number of new genes in the kidney. Since knockout technologies have evolved in the early eighties the mouse has become a valuable model organism. Researchers can now artificially eliminate the expression of specific genes in a mammalian organism and examine the phenotype. New developments have emerged that allow investigators to knock out a gene specifically in the kidney. Several kidney-specific promoters provide valuable tools and bacterial artificial chromosome (BAC) based techniques like recombineering will enhance both number and accuracy of new mouse lines with spatially controlled gene expression. In addition to spatial control, tetracycline- or tamoxifen-inducible systems, provide the possibility of influencing the temporal expression pattern of a gene enabling researchers to dissect its functions in adult organisms. Knocking out a gene will continue to be the gold standard for defining the role of a specific gene whereas tissue-specific gene knockdown using RNA interference represents an alternative approach for generating lower-priced and fast loss of function models. In addition to reverse genetic approaches, forward genetic techniques like random mutagenesis in mice continue to evolve and will enhance our understanding of disease mechanisms in the kidney.     

Liposome-mediated gene therapy in the kidney

Gene therapy directed to the kidney has been attempted to improve renal disorders such as inherited kidney diseases and common renal diseases that cause interstitial fibrosis, tubular atrophy, and glomerulosclerosis. Viral and non-viral vectors have been tried and been modulated to obtain sufficient transgene expression. However, gene delivery to the kidney is usually difficult because of characteristics of renal cell biology. Among non-viral vectors, the liposome system is a promising procedure for kidney-targeted gene therapy. Using cationic liposome, tubular cells were effectively transduced by retrograde injection of liposome/cDNA complex. Although transgene expression was reportedly modest using cationic liposomes, this method improved renal disease models such as carbonic anhydrase II deficiency and unilateral ureteral obstruction. In contrast, HVJ-liposome system is an effective transfection method to glomerular cells using intra-renal arterial infusion and improved glomerular disease models such as glomerulonephritis and glomerulosclerosis. In addition, intra-renal pelvic injection of DNA by HVJ-liposome system showed transgene expression in interstitial fibroblasts. In kidney-targeted gene therapy, liposome-mediated gene transfer is an attractive method because of its simplicity and reduced toxicity. In spite of modest transgene expression, several renal disease models were successfully modulated by liposome system. Although one limitation of liposome-mediated gene delivery is the duration of transgene expression, the liposome/cDNA complex can be repeatedly administered due to the absence of an immune response.